Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

• Once ICP reaches around 25mmHg

INCREASED INTRACRANIAL marked elevation in ICP will be noted.


PRESSURE (IICP)
Transcribed by: Julia Rae D. delos Santos

INTRACRANIAL PRESSURE

Pressure in the skull that results from the volume


of 3 essential components:

1. CSF, 75 mL PATHOPHYSIOLOGY
2. 2. Blood Volume, 75 mL
3. CNS tissue, 1400g Brain tissue/
CSF /
Blood Volume

No room for expansion

Compliance (Monro-Kellie Hypothesis)

• Normal ICP is between 8-15mmHg. Displacement of CSF Blood flow in the


• 3 components maintain a state of into Spinal Cavity brain
equilibrium.
• The intact cranium cannot be expanded.
Can only accommodate Can only maintain decreased
• Monro-Kelie hypothesis: because of a
CSF to a certain point blood flow for a period of time
limited space for expansion within the
skull, an increase in any one of the
components causes a change in the Limit reached Acidotic Cerebral Metabolism
volume of the others.
➢ Any increase in one of the
elements must be balanced or IICP
compensated by a proportional
constriction either or both of the
other components. Acidotic env. Causes cerebral swelling

INCREASED INTRACRANI AL PRESSURE (IICP) Worsening cerebral hypoxia and ischemia


• A syndrome characterized by increase in
the amount of CNS tissue, CSF fluid or Death Brain herniation
blood leading to an ICP greater than
15mmHg.
Brainstem compression

Death
Increased ICP can Impede the  Doll’s eye phenomena –
circulation to the brain, stimulates further abnormal when present and may
swelling, impedes the absorption of CSF, affect occur as the client begins to
the functioning of nerve cells, and lead to
experience a decrease in LOC.
brainstem compression and death.
Occurs when the client’s head is
May shift brain tissue, resulting in moved from side to side and the
herniation, a frequently fatal event.
eye remain in a fixed midline
position
CLINICAL MANIFESTATIONS  Decortication
 Decerebration
When IICP increases to the when ability to
adjust has reached its limits, neural function is DIAGNOSTICS
impaired. (changes in LOC)
CT scan, MRI, cerebral angiogram, EEG, Caloric
▪ Lethargy – earliest sign test (oculovestibular response)
▪ Sudden change in condition
▪ Patient becomes stuporous and may ICP monitoring device:
react only to loud auditory or painful
o Purpose: to identify increased pressure
stimuli.
early in its course, to quantify the degree
▪ When coma is profound, pupils are
of elevation, to initiate appropriate
dilated and fixed, respirations are
treatment, to provide access to CSF for
impaired → death.
sampling and drainage, to evaluate the
▪ CUSHING’S TRIADE (late sign)
effectiveness of treatment.
 HYPERtension + Widened pulse
o 3 ways to measure ICP:
pressure
➢ Intraventricular catheter – most
 BRADYcardia
accurate
 BRADYpnea
➢ Subarachnoid/Subdural
screw/bolt
ASSESSMENTS
➢ Epidural Sensor
▪ Headache
▪ Vomiting MEDICAL MANAGEMENT
▪ Diplopia (CN VI)
Increased ICP is a true emergency and
▪ Body temperature may be elevated or must be treated promptly.
subnormal
Goals:
▪ Pupillary changes
▪ Papilledema – swelling of optic nerve o Invasive monitoring of ICP
▪ Lateralizing sign – this is a contralateral o Decreasing cerebral edema
loss of motor function due to decussation o Lowering the volume of CSF
of motor fibers at the level of medulla
o Decreasing cerebral blood volume while
oblongata. maintaining cerebral perfusion
▪ Pupillary changes:
o Pharmacologic therapy
 Ipsilateral pupil dilatation (CN III
compression) o Patient requires care in the critical care
unit.
 Bilateral pupil dilatations
▪ Brainstem function impairment
PHARMACOTHERAPY

▪ Diuretics (Mannitol, Lasix)


▪ Anticonvulsants (Valium, Dilantin,
Phenobarbital, Tegretol)
▪ Antipyretics
▪ Muscle relaxants
▪ BP medication
▪ Corticosteroids – Decadron
(Dexamethasone)
▪ Antacids / H2 receptors
▪ Anticoagulants
▪ Stool softener
▪ Intravenous fluids
▪ Electrolyte replacement

Note: opiates and sedatives are contraindicated


to the client with IICP. (induce cerebral hypoxia
and vasodilation)

TX & COLLABORATIVE MANAGEMENT

▪ Adequate oxygenation / Maintain


respiratory function
▪ Position: semi-fowler’s
▪ Protect patient from injury
▪ Avoid factors that increases ICP (N/V,
sneezing and coughing, Valsalva
maneuver, over suctioning, restraints,
rectal examination, enema, flexion of
waist, hip or neck)
▪ Control fever
▪ Monitor intake and output
▪ Limit fluid intake to 1200mL/day

SURGICAL INTERVENTIONS

▪ Ventriculoperitoneal shunt – shunts CSF


from the ventricles into the peritoneum
▪ Craniotomy for space occupying lesions
and cerebral hematoma

Complications: Herniation, seizures cognitive


deficits, motor deficits, sensory deficits, coma,
death.

You might also like